In this in vitro study, they showed that BM-MSC-derived EVs can play a protective role in diabetic retinopathy via TLR4/NF-κB axis repression by upregulating miR-486-3p expression from high-glucose-treated Muller cells. The gene discussed is TLR4; the disease is diabetic retinopathy.